Hims & Hers Health, Inc. (HIMS) Q3 Revenues Beat; Guides Above
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Hims & Hers Health, Inc. Reports Third Quarter 2021 Financial Results
November 10, 2021 4:01 PM ESTQ3 2021 revenue grows 79% year-over-year to $74.2 million
Q3 2021 ending member subscriptions grow 95% year-over-year to 551,000
Exceeds Q3 2021 revenue guidance, raises full year 2021 guidance
SAN FRANCISCO--(BUSINESS WIRE)-- Hims & Hers Health, Inc. (Hims & Hers, NYSE: HIMS), a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, today reported financial results for the third quarter ending September 30, 2021.
This latest quarter of results shows that our vision to create a new front door to healthcare is resonating, said Andrew Dudum, CEO and... More
